These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6230259)

  • 1. The influence of androgens on insulin resistance.
    Shoupe D; Lobo RA
    Fertil Steril; 1984 Mar; 41(3):385-8. PubMed ID: 6230259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for the importance of peripheral tissue events in the development of hirsutism in polycystic ovary syndrome.
    Lobo RA; Goebelsmann U; Horton R
    J Clin Endocrinol Metab; 1983 Aug; 57(2):393-7. PubMed ID: 6223045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased 5 alpha-reductase activity in idiopathic hirsutism.
    Serafini P; Lobo RA
    Fertil Steril; 1985 Jan; 43(1):74-8. PubMed ID: 3155511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of leuprolide and dexamethasone on hair growth and hormone levels in hirsute women: the relative importance of the ovary and the adrenal in the pathogenesis of hirsutism.
    Rittmaster RS; Thompson DL
    J Clin Endocrinol Metab; 1990 Apr; 70(4):1096-102. PubMed ID: 2156885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum levels of 3alpha-androstanediol glucuronide in young women with polycystic ovary syndrome, idiopathic hirsutism and in normal subjects.
    Meczekalski B; Slopien R; Warenik-Szymankiewicz A
    Eur J Obstet Gynecol Reprod Biol; 2007 May; 132(1):88-92. PubMed ID: 16979812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin resistance in polycystic ovary syndrome.
    Shoupe D; Kumar DD; Lobo RA
    Am J Obstet Gynecol; 1983 Nov; 147(5):588-92. PubMed ID: 6227251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of obesity and chronic hyperinsulinemia on gonadotropin release and gonadal steroid secretion in the polycystic ovary syndrome.
    Dunaif A; Mandeli J; Fluhr H; Dobrjansky A
    J Clin Endocrinol Metab; 1988 Jan; 66(1):131-9. PubMed ID: 2961783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association of serum androgens and insulin resistance with fat distribution in polycystic ovary syndrome.
    Yucel A; Noyan V; Sagsoz N
    Eur J Obstet Gynecol Reprod Biol; 2006 May; 126(1):81-6. PubMed ID: 16337726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No changes of peripheral insulin resistance in polycystic ovary syndrome after long-term reduction of endogenous androgens with leuprolide.
    Lasco A; Cucinotta D; Gigante A; Denuzzo G; Pedulla M; Trifiletti A; Frisina N
    Eur J Endocrinol; 1995 Dec; 133(6):718-22. PubMed ID: 8548057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum total L-carnitine levels in non-obese women with polycystic ovary syndrome.
    Fenkci SM; Fenkci V; Oztekin O; Rota S; Karagenc N
    Hum Reprod; 2008 Jul; 23(7):1602-6. PubMed ID: 18378560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin resistance in nonobese patients with polycystic ovarian disease.
    Chang RJ; Nakamura RM; Judd HL; Kaplan SA
    J Clin Endocrinol Metab; 1983 Aug; 57(2):356-9. PubMed ID: 6223044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of finasteride, a 5 alpha-reductase inhibitor, on circulating androgens and gonadotropin secretion in hirsute women.
    Fruzzetti F; de Lorenzo D; Parrini D; Ricci C
    J Clin Endocrinol Metab; 1994 Sep; 79(3):831-5. PubMed ID: 8077369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum 5-androstene-3 beta,17 beta-diol sulphate and 5 alpha-androstane-3 alpha,17 beta-diol sulphate in hirsute females with polycystic ovarian disease.
    Montalto J; Funder JW; Yong AB; Davies HE; Connelly JF
    J Steroid Biochem; 1990 Jun; 36(1-2):67-74. PubMed ID: 2362450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated bioactive luteinizing hormone in women with the polycystic ovary syndrome.
    Lobo RA; Kletzky OA; Campeau JD; diZerega GS
    Fertil Steril; 1983 May; 39(5):674-8. PubMed ID: 6220924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. So similar and so different: Circulating androgens and androgen origin in bulimic women.
    Naessén S; Söderqvist G; Carlström K
    J Steroid Biochem Mol Biol; 2019 Jan; 185():184-188. PubMed ID: 30172682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disturbances of androgen secretion and metabolism in polycystic ovary syndrome.
    Lobo RA
    Clin Obstet Gynaecol; 1985 Sep; 12(3):633-47. PubMed ID: 2933204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is 3 alpha-androstanediol a marker of peripheral hirsutism?
    Toscano V; Sciarra F; Adamo MV; Petrangeli E; Foli S; Caiola S; Conti C
    Acta Endocrinol (Copenh); 1982 Feb; 99(2):314-20. PubMed ID: 6460409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Insulin resistance and serum concentrations of ovarian and adrenal androgen in obese women without additional disease and with policystic ovary syndrome].
    Olszanecka-Glinianowicz M; Banaś M; Zahorska-Markiewicz B; Kuglin D; Mokrzycka J; Mentel A
    Endokrynol Pol; 2005; 56(6):921-6. PubMed ID: 16821212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum Fetuin-A levels, insulin resistance and oxidative stress in women with polycystic ovary syndrome.
    Enli Y; Fenkci SM; Fenkci V; Oztekin O
    Gynecol Endocrinol; 2013 Dec; 29(12):1036-9. PubMed ID: 23961784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normal and elevated 3 alpha-androstanediol glucuronide concentrations in women with various causes of hirsutism and its correlation with degree of hirsutism and androgen levels.
    Pang S; Wang M; Jeffries S; Riddick L; Clark A; Estrada E
    J Clin Endocrinol Metab; 1992 Jul; 75(1):243-8. PubMed ID: 1535633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.